BIOVAXYS APPOINTS FORMER SANOFI VACCINES EXECUTIVE TO BOARD OF DIRECTORS
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 08 2025
0mins
Source: PRnewswire
New Board Appointment: BioVaxys Technology Corp. has appointed Dr. James Tartaglia, a former executive at Sanofi Vaccines, to its Board of Directors, filling a vacancy left by Anthony Dutton's resignation.
Dr. Tartaglia's Expertise: With over 34 years in vaccine R&D, Dr. Tartaglia has been instrumental in the development and licensure of numerous vaccines and will contribute his extensive experience to BioVaxys's vaccine programs.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
